51ÊÓÆµ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 51ÊÓÆµ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • 51ÊÓÆµ

    51ÊÓÆµ

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Oct 13 2026 8:59 AM

Full Issue

HHS Backs DEA's Effort To Classify Synthetic Kratom Extracts 7-OH And MGPI

The recommendation would make 7-hydroxymitragynine and mitragynine pseudoindoxyl (MGPI) Schedule I drugs if either compound or a combination of both exceeds “1 milligram per gram in solid powders, encapsulated material, or other solid forms, or exceeds 1 milligram per milliliter in liquid preparations.� Plus, hospitals again are asking the courts to block the 340B rebate program.

The Department of Health and Human Services (HHS) on Friday added its recommendations to the Drug Enforcement Administration’s (DEA) move to schedule synthetic kratom extracts, putting its support behind the push to regulate the substances colloquially called “gas station opioid.� In July, the DEA announced plans to temporarily schedule a psychoactive compound derived from kratom called 7-hydroxymitragynine (7-OH) and other related compounds as Schedule I, placing it in a category indicating no accepted medical use and a high potential for abuse. (Choi, 10/9)

51ÊÓÆµ Health News: People Say These Peptides Hurt Them. Their Stories Are Muffled In MAHA’S Push For Medical Freedom

After the third day of squirting an experimental drug up his nose, Dylan Meetze felt horrible. “It was like I was underwater, like it took the most to do anything,� he said. Meetze stopped taking the drug but endured fatigue and anxiety for months afterward, and his eyes and muscles twitched, he said. (Maxmen, 10/13)

More health news from the Trump administration —

Hospitals are suing the HHS for a second time over the agency’s controversial plan to convert 340B drug discounts into a rebate system. The American Hospital Association, along with a Maine hospital lobby and four safety-net hospitals, filed the complaint Friday alleging that the switch from upfront discounts to post-purchase rebates threatens the financial viability of hospitals in the drug discount program. (Hughes, 10/12)

A new type of cancer treatment — vaccines — is so promising that it demands a national effort to expedite discoveries, said the director of the National Cancer Institute, Dr. Anthony Letai. “We can do things that would not otherwise be done,� he said of new resources being made available at the National Institutes of Health. “We can place big bets on new ideas.� (Kolata, 10/9)

A man who was injured when an ICE officer’s car ran over him has had surgery on his leg but needs additional procedures to reconstruct the leg and other parts of his body, an advocate for the man said Monday. Miguel Parra Hernandez, 48, had leg and hip injuries and a shattered ankle after the officer’s vehicle struck him during a pursuit Saturday, said Cesar Espinosa, a co-founder and the executive director of FIEL, who was speaking on Parra’s behalf. Parra cannot put weight on his leg for six weeks and must wait for swelling to reduce before doctors can perform additional surgery, he said at a news conference Monday. (Gamboa, Thompson and Gonzalez, 10/13)

Supporters of "Medicare for All" now outnumber opponents by nearly 2-to-1, according to a new survey of U.S. adults from the Axios-Ipsos American Health Index. Two-thirds of all survey respondents — and half of Republicans — said the federal government should be willing to spend more tax dollars to lower health care costs for Americans. (Talev, 10/13)

In election news —

Republican officials and conservative social media users spread unfounded rumors in recent days that state Rep. James Talarico, the Democratic nominee in a competitive Texas Senate race, had suffered a mental health crisis. Questions about Talarico’s whereabouts began spreading after the candidate was not seen in public for nine days. But he and his campaign have repeatedly attributed his absence to the flu. (Goldin and Bedayn, 10/12)

51ÊÓÆµ Health News: Fears About Kids’ Online Safety Unite Democrats And Republicans

The U.S. Senate candidates in Texas could hardly be more different: James Talarico, a former seminarian turned Democratic state lawmaker who speaks in calm cadences about love and empathy, and Ken Paxton, the pugnacious Republican state attorney general who speaks about a refusal to compromise. They share an enemy, though. They dislike social media’s effects on children’s mental health. Talarico, who did not respond to a request for comment, has endorsed a social media ban for kids under 16, while denouncing “predatory algorithms that divide us on an hourly, daily basis.� As a legislator, he co-authored a bill targeting explicit deepfakes — digital imitations of individuals that are often made or manipulated by artificial intelligence and used for harassment on social media. (Tahir, 10/13)

Abortion was a dominant theme in the 2022 midterm elections, which took place just months after the Supreme Court overturned Roe v. Wade. This time around, the issue isn’t top of mind for as many voters — but Democrats are still betting it could motivate their base and independents, particularly in a handful of high-profile races. (Bendix, 10/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, October 13
  • Friday, October 9
  • Thursday, October 8
  • Wednesday, October 7
  • Tuesday, October 6
  • Monday, October 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • 51ÊÓÆµ
  • Privacy Policy

© 2026 51ÊÓÆµ